Mirae Asset Global Investments
JANX icon

Mirae Asset Global Investments’s Janux Therapeutics JANX Stock Holding History

Mirae Asset Global Investments’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.9K Sell
2,727
-446
-14% -$6.46K ﹤0.01% 1382
2026
Q1 		$44.1K Buy
3,173
+250
+9% +$3.43K ﹤0.01% 1318
2025
Q4 		$40.3K Buy
2,923
+600
+26% +$14.1K ﹤0.01% 1439
2025
Q3 		$56.8K Buy
2,323
+37
+2% +$901 ﹤0.01% 1318
2025
Q2 		$52.8K Buy
2,286
+339
+17% +$8.93K ﹤0.01% 1248
2025
Q1 		$56.7K Buy
1,947
+198
+11% +$7.46K ﹤0.01% 1220
2024
Q4 		$94.6K Sell
1,749
-138
-7% -$7.3K ﹤0.01% 1157
2024
Q3 		$87.3K Buy
1,887
+339
+22% +$14.7K ﹤0.01% 1211
2024
Q2 		$62.4K Buy
+1,548
New +$72.7K ﹤0.01% 1203

Other funds holding JANX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mirae Asset Global Investments's JANX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Janux Therapeutics (JANX) stake by 14% in Q2 2026, selling an estimated $6.46K and leaving 2,727 shares worth $41.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1382.

Mirae Asset Global Investments first reported a position in JANX in Q2 2024 and has held it in 9 quarters since. The position peaked at $94.6K in Q4 2024. 61 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Mirae Asset Global Investments held 2,727 shares of Janux Therapeutics worth $41.9K as of Q2 2026.
  • Mirae Asset Global Investments sold 446 Janux Therapeutics shares in Q2 2026, an estimated $6.46K.
  • Janux Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1382 holding.
  • Mirae Asset Global Investments first reported a position in Janux Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global Investments's Janux Therapeutics position peaked at $94.6K in Q4 2024.
  • 61 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.